aregalu 14 mg tabletki powlekane
krka, d.d., novo mesto - teriflunomidum - tabletki powlekane - 14 mg
terebyo 14 mg tabletki powlekane
sandoz gmbh - teriflunomidum - tabletki powlekane - 14 mg
bozilos 14 mg tabletki powlekane
egis pharmaceuticals plc - teriflunomidum - tabletki powlekane - 14 mg
teriflunomide pharmascience 14 mg tabletki powlekane
pharmascience international limited - teriflunomidum - tabletki powlekane - 14 mg
teriflunomide +pharma 14 mg tabletki powlekane
+pharma arzneimittel gmbh - teriflunomidum - tabletki powlekane - 14 mg
teriflunomide zentiva 14 mg tabletki powlekane
zentiva, k.s. - teriflunomidum - tabletki powlekane - 14 mg
tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - leki immunosupresyjne - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
boxarid 14 mg tabletki powlekane
gedeon richter plc. - teriflunomidum - tabletki powlekane - 14 mg
clefirem 14 mg tabletki powlekane
bausch health ireland ltd. - teriflunomidum - tabletki powlekane - 14 mg